Thermo Fisher Scientific Inc. (NYSE:TMO) shares saw strong trading volume on Thursday . 1,257,031 shares were traded during mid-day trading, an increase of 11% from the previous session’s volume of 1,134,402 shares.The stock last traded at $152.98 and had previously closed at $154.67.

A number of equities research analysts recently commented on the stock. BTIG Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a research note on Friday, July 22nd. Citigroup Inc. increased their price objective on shares of Thermo Fisher Scientific from $160.00 to $182.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Leerink Swann reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Sunday, May 29th. Jefferies Group reissued a “hold” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 4th. Finally, Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Two research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $159.66.

The firm has a market capitalization of $60.55 billion and a PE ratio of 30.72. The stock has a 50 day moving average price of $155.46 and a 200-day moving average price of $145.53.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, July 28th. The company reported $2.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.01 by $0.02. The firm had revenue of $4.54 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period in the previous year, the firm earned $1.84 earnings per share. Thermo Fisher Scientific’s revenue was up 6.2% on a year-over-year basis. On average, analysts expect that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend is Tuesday, September 13th.

In related news, VP Seth H. Hoogasian sold 5,023 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $156.00, for a total value of $783,588.00. Following the transaction, the vice president now owns 31,914 shares of the company’s stock, valued at approximately $4,978,584. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director C Martin Harris sold 390 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $157.33, for a total value of $61,358.70. Following the completion of the transaction, the director now directly owns 4,648 shares in the company, valued at approximately $731,269.84. The disclosure for this sale can be found here.

A number of institutional investors recently modified their holdings of TMO. KBC Group NV boosted its position in shares of Thermo Fisher Scientific by 84.4% in the fourth quarter. KBC Group NV now owns 122,703 shares of the company’s stock worth $17,405,000 after buying an additional 56,169 shares in the last quarter. Employees Retirement System of Texas boosted its position in shares of Thermo Fisher Scientific by 21.1% in the fourth quarter. Employees Retirement System of Texas now owns 52,800 shares of the company’s stock worth $7,490,000 after buying an additional 9,200 shares in the last quarter. Argent Trust Co boosted its position in shares of Thermo Fisher Scientific by 0.8% in the third quarter. Argent Trust Co now owns 10,619 shares of the company’s stock worth $1,299,000 after buying an additional 80 shares in the last quarter. Stephens Inc. AR boosted its position in shares of Thermo Fisher Scientific by 88.5% in the fourth quarter. Stephens Inc. AR now owns 15,019 shares of the company’s stock worth $2,130,000 after buying an additional 7,052 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its position in shares of Thermo Fisher Scientific by 1.3% in the fourth quarter. Advisors Asset Management Inc. now owns 66,067 shares of the company’s stock worth $9,372,000 after buying an additional 865 shares in the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.